tirzepatide combined with semaglutide Combining ESG or for Medical Weight Loss Tirzepatide vs. Semaglutide: Which GLP-1
Description
Injection Because both forms use the same active drug, they can be similarly effective in principle
The SURMOUNT-1 trial enrolled adults with obesity (or overweight with comorbidities) without diabetes and treated them with tirzepatide 5, 10, or 15 mg versus placebo for 72 weeks
Sobo GLP-1 Weight Loss Dr
These usually appear within a few hours of the injection and resolve on their own within 3 to 5 days
Key takeaways Brand tirzepatide (Mounjaro & Zepbound) is fully FDA-approved, while compounded versions are mostly illegal in 2026
Long-term considerations include the recognition that tirzepatide is a chronic disease management medication rather than a short-term intervention
